Currently, prophylactic mastectomy and/or prophylactic annexectomy are used to decrease breast cancer risk in carriers with BRCA1 mutations; however, there is an urgent need to develop efficient and less aggressive strategies. This evidence concerns the gene BRCA1 and breast cancer.